Literature DB >> 15652672

A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.

Muneki Hotomi1, Yorihiko Ikeda, Masaki Suzumoto, Kazuma Yamauchi, Bruce A Green, Gary Zlotnick, Dewan S Billal, Jun Shimada, Keiji Fujihara, Noboru Yamanaka.   

Abstract

Outer membrane protein P4, together with P6, is highly conserved among all typeable and nontypeable strains of Haemophilus influenzae (H. influenzae). Thus, the protein is an attractive antigen for the inclusion in a vaccine against nontypeable H. influenzae (NTHi). However, the ability of P4 to induce antibodies protective against NTHi infections is still controversial. In this study, we investigated the specific mucosal immune responses against NTHi induced by intranasal immunization with the lipidated form of recombinant P4 protein (rP4) and non-fatty acylated recombinant P6 protein (rP6) with or without cholera toxin (CT) in BALB/c mice model. Intranasal immunization with either rP4+CT, a mixture of rP4 and rP6+CT, or rP4 and rP6 without CT elicited anti-rP4 specific IgG antibody in serum of mice. Intranasal immunization with either rP4+CT or a mixture of rP4, rP6+CT elicited anti-rP4 specific IgA antibody in nasopharyngeal washing (NPW), while intranasal immunization with rP4 and rP6 without CT did not induced anti-rP4 specific IgA antibody responses in NPWs. Sera from mice intranasally immunized with rP4+CT and a mixture of rP4, rP6+CT also showed bactericidal activity. Significant clearance of NTHi in nasopharynx was seen 3 days after the inoculation of live NTHi in mice intranasally immunized with rP4+CT. The current findings suggested that P4 would be a useful antigen as the component of the vaccine to induce protective immune responses against NTHi. The use of an intranasal vaccine composed of the different surface protein antigens is an attractive strategy for the development of a vaccine against NTHi.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652672     DOI: 10.1016/j.vaccine.2004.08.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

Review 1.  NAD+ utilization in Pasteurellaceae: simplification of a complex pathway.

Authors:  Gabriele Gerlach; Joachim Reidl
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

2.  Crystal structure and immunogenicity of the class C acid phosphatase from Pasteurella multocida.

Authors:  Harkewal Singh; Thomas J Malinski; Thomas J Reilly; Michael T Henzl; John J Tanner
Journal:  Arch Biochem Biophys       Date:  2011-03-01       Impact factor: 4.013

3.  Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary Haemophilus influenzae infection.

Authors:  Wenchao Li; Xinyun Zhang; Ying Yang; Qingqin Yin; Yan Wang; Yong Li; Chuan Wang; Sandy M Wong; Ying Wang; Howard Goldfine; Brian J Akerley; Hao Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-09       Impact factor: 11.205

Review 4.  Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.

Authors:  Timothy F Murphy
Journal:  Clin Vaccine Immunol       Date:  2015-03-18

5.  Certain site-directed, nonenzymatically active mutants of the Haemophilus influenzae P4 lipoprotein are able to elicit bactericidal antibodies.

Authors:  Bruce A Green; Elizabeth Baranyi; Thomas J Reilly; Arnold L Smith; Gary W Zlotnick
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Recognition of nucleoside monophosphate substrates by Haemophilus influenzae class C acid phosphatase.

Authors:  Harkewal Singh; Jonathan P Schuermann; Thomas J Reilly; Michael J Calcutt; John J Tanner
Journal:  J Mol Biol       Date:  2010-10-08       Impact factor: 5.469

7.  Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae.

Authors:  K L Ostberg; M W Russell; T F Murphy
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

Review 8.  Mouse models for the study of mucosal vaccination against otitis media.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

9.  VapC-1 of nontypeable Haemophilus influenzae is a ribonuclease.

Authors:  Dayle A Daines; Mack H Wu; Sarah Y Yuan
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

10.  Microarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae.

Authors:  Julien Gouré; Wendy A Findlay; Vincent Deslandes; Anne Bouevitch; Simon J Foote; Janet I MacInnes; James W Coulton; John H E Nash; Mario Jacques
Journal:  BMC Genomics       Date:  2009-02-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.